-
1
-
-
0034125023
-
Experimental subretinal neovascularization is inhibited by adenovirus-mediated soluble VEGF/fit-1 receptor gene transfection: A role of VEGF and possible treatment for SRN in age-related macular degeneration
-
Honda M, Sakamoto T, Ishibashi T, et al. Experimental subretinal neovascularization is inhibited by adenovirus-mediated soluble VEGF/fit-1 receptor gene transfection: a role of VEGF and possible treatment for SRN in age-related macular degeneration. Gene Ther 2000;7:978-985.
-
(2000)
Gene Ther
, vol.7
, pp. 978-985
-
-
Honda, M.1
Sakamoto, T.2
Ishibashi, T.3
-
2
-
-
2142701648
-
Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization
-
Murata T, He S, Hangai M, et al. Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization. Invest Ophthalmol Vis Sci 2000;41:2309-2317.
-
(2000)
Invest Ophthalmol Vis Sci
, vol.41
, pp. 2309-2317
-
-
Murata, T.1
He, S.2
Hangai, M.3
-
3
-
-
0035889668
-
Looking into anti-angiogenic gene therapies for disorders of the eye
-
Rasmussen HS, Rasmussen CS, Durham RG, et al. Looking into anti-angiogenic gene therapies for disorders of the eye. Drug Discov Today 2001;15;6:1171-1175.
-
(2001)
Drug Discov Today
, vol.15
, Issue.6
, pp. 1171-1175
-
-
Rasmussen, H.S.1
Rasmussen, C.S.2
Durham, R.G.3
-
4
-
-
0035514256
-
Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD)
-
Rasmussen H, Chu KW, Campochiaro P, et al. Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD). Hum Gene Ther 2001;12:2029-2032.
-
(2001)
Hum Gene Ther
, vol.12
, pp. 2029-2032
-
-
Rasmussen, H.1
Chu, K.W.2
Campochiaro, P.3
-
5
-
-
6844241942
-
Subretinal administration of tissue-type plasminogen activator to speed the drainage of subretinal hemorrhage
-
Saika S, Yamanaka A, Yamanaka A, et al. Subretinal administration of tissue-type plasminogen activator to speed the drainage of subretinal hemorrhage. Graefes Arch Clin Exp Ophthalmol 1998;236:196-201.
-
(1998)
Graefes Arch Clin Exp Ophthalmol
, vol.236
, pp. 196-201
-
-
Saika, S.1
Yamanaka, A.2
Yamanaka, A.3
-
6
-
-
0034443830
-
Less traumatic internal drainage instrument for subretinal fluid
-
Nishimura A, Segawa Y, Shirao Y, et al. Less traumatic internal drainage instrument for subretinal fluid. Retina 2000;20:693.
-
(2000)
Retina
, vol.20
, pp. 693
-
-
Nishimura, A.1
Segawa, Y.2
Shirao, Y.3
-
7
-
-
0029126460
-
Prospective, randomised, controlled trial comparing suture needle drainage and argon laser drainage of subretinal fluid
-
Aylward GW, Orr G, Schwartz SD, et al. Prospective, randomised, controlled trial comparing suture needle drainage and argon laser drainage of subretinal fluid. Br J Ophthalmol 1995;79:724-727.
-
(1995)
Br J Ophthalmol
, vol.79
, pp. 724-727
-
-
Aylward, G.W.1
Orr, G.2
Schwartz, S.D.3
-
8
-
-
4243416747
-
A new procedure for retinal transplantation
-
Abstract
-
Lazar E, del Cerro M. A new procedure for retinal transplantation. Invest Ophthalmol Vis Sci 1990;31:593S. Abstract.
-
(1990)
Invest Ophthalmol Vis Sci
, vol.31
-
-
Lazar, E.1
Del Cerro, M.2
-
9
-
-
0031049524
-
Modified needle drainage of subretinal fluid for conventional scleral buckling procedures
-
Azad RV, Talwar D, Pai A. Modified needle drainage of subretinal fluid for conventional scleral buckling procedures. Ophthalmic Surg Lasers 1997;28:165-167.
-
(1997)
Ophthalmic Surg Lasers
, vol.28
, pp. 165-167
-
-
Azad, R.V.1
Talwar, D.2
Pai, A.3
-
10
-
-
0026894401
-
Surgical management of exudative maculopathies: Preliminary report
-
Krasnov MM, Stolyarenko GE. Surgical management of exudative maculopathies: preliminary report. Eur J Ophthalmol 1992;2:122-128.
-
(1992)
Eur J Ophthalmol
, vol.2
, pp. 122-128
-
-
Krasnov, M.M.1
Stolyarenko, G.E.2
|